focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: FTSE 100 seen flat; Just Eat and Sainsbury's partner

Mon, 16th Jan 2023 07:50

(Alliance News) - With US financial markets closed for a public holiday on Monday and after better-than-expected data for the UK economy on Friday, stocks in London were set to start the week slightly higher.

UK gross domestic product grew by 0.1% month-on-month in November, slowing from October's unrevised growth of 0.5%. The economy defied expectations which anticipated it to shrink by 0.2% in November, according to consensus cited by FXStreet.

GDP was helped by the start of the football World Cup, which boosted consumer-facing sectors, the Office for National Statistics explained.

In further signs of emerging stability for the UK economy, the average asking price for a house in the UK rose in January, according to the data from Rightmove on Monday.

The average price of a property coming to the market for sale rose to GBP362,438 in January, up 0.9% from GBP359,137 in December. Rightmove said this was the biggest increase at this time of year since 2020.

"After the market's uncertain final few months of 2022, this familiar seasonality is a tentative sign of stability...It's still early days, but this is a more encouraging start to the year than many anticipated," Rightmove said.

In UK company news, ITM Power issued a warning on its full-year results, while AstraZeneca completed its acquisition of clinical-stage biotechnology company Neogene Therapeutics.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called flat at 7,844.00

----------

Hang Seng: down 0.2% at 21,706.14

Nikkei 225: closed down 1.1% at 25,822.32

S&P/ASX 200: closed up 0.8% at 7,388.20

----------

DJIA: closed up 112.64 points, or 0.3%, at 34,302.61

S&P 500: closed up 15.92 points, or 0.4%, at 3,999.09

Nasdaq Composite: closed up 78.05 points, or 0.7%, at 4,000.70

----------

EUR: higher at USD1.0835 (USD1.0820)

GBP: higher at USD1.2230 (USD1.2209)

USD: higher at JPY128.10 (JPY127.85)

Gold: higher at USD1,916.75 per ounce (USD1,911.40)

(Brent): lower at USD84.63 a barrel (USD84.80)

(changes since previous London equities close)

----------

ECONOMICS

----------

Monday's key economic events still to come:

US Martin Luther King Day holiday. Financial markets closed.

----------

The UK foreign secretary will resume talks with his European Commission counterpart as speculation mounts that London and Brussels could be nearing a breakthrough on the Northern Ireland protocol. James Cleverly will speak to Maros Sefcovic, the commission's vice-president, on Monday over a proposal to iron out issues with post-Brexit trade arrangements affecting Northern Ireland and Great Britain. Political expectation about the prospect of an accord has grown, with suggestions that cross-Channel relations have improved since Rishi Sunak became prime minister. The announcement last week that a deal had been reached on sharing real-time data on goods travelling from Great Britain to Northern Ireland was seen as a step towards an overall resolution.

----------

BROKER RATING CHANGES

----------

Investec cuts HSBC to 'hold'

----------

Jefferies cuts abrdn to 'hold' ('buy') - price target 215 (210) pence

----------

Bofa cuts Burberry to 'underperform' ('neutral') - price target 2,000 pence

----------

COMPANIES - FTSE 100

----------

Pharmaceutical firm AstraZeneca completed its acquisition of Neogene Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and manufacturing of T-cell receptor therapies. Neogene Therapeutics now will operate as a wholly-owned subsidiary of Astra, with operations in both Amsterdam and Santa Monica, California. AstraZeneca bought Neogene Therapeutics for an initial payment of USD200 million. It will pay an additional consideration of up to USD120 million if milestones are met.

----------

Food delivery app Just Eat announced a partnership with supermarket chain J Sainsbury for grocery delivery in the UK. The partnership will launch with more than 175 Sainsbury's stores by the end of February. As a result of the contact, Just Eat customer will have access to thousands of products, including Sainsbury's own brand products, for delivery, it says.

----------

COMPANIES - FTSE 250

----------

Asset manager Ashmore said that in the final quarter of 2022 its assets under management increased by USD1.2 billion to an estimated USD57.2 billion. At September 30, Ashmore had USD56.0 billion in AuM. Ashmore said the increase was due to a positive investment performance of USD3.8 billion, offset by net outflows of USD2.6 billion. "Reflecting a modest easing of global macro concerns, the Emerging Markets delivered strong returns over the quarter with the main fixed income and equity benchmark indices rising by between 5% and 10%. Ashmore's active investment processes delivered outperformance in the period across a broad range of fixed income and equity strategies, reflecting the typical profile of alpha creation as markets begin to recover from oversold levels," Ashmore explained.

----------

Primary care property investor Assura said it had a portfolio of 607 properties with an annualised rent roll of GBP141.6 million as of the end of 2022. It is currently on site with 11 developments which have a total cost of GBP121 million. However, Assura noted its net initial yield as of December 31 was 4.86%. It explained this represented a 7% reduction in its portfolio value which, at the end of 2022, stood at GBP2.7 billion.

----------

QinetiQ announced it has won a GBP80 million contract with the UK Ministry of Defence. The contract will provide specialist mission data and electronic warfare skills solutions, alongside training and IT support, the firm explained. QinetiQ will work with the UK MOD for a 10-year period. Chief Executive James Willis said: "The contract demonstrates how the MoD works closely with industry to build the skills of the future and introduce innovative approaches to enhance mission capability." QinetiQ is an engineering firm operating primarily in the defence and security markets.

----------

OTHER COMPANIES

----------

ITM Power said it has become clear that the outcome for the year ending April 30 will be "materially different" from current guidance, with lower revenue and a higher earnings before interest, taxation, depreciation and amortisation loss. The hydrogen-generating electrolyser system manufacturer said this conclusion came following a review of its operations after the appoint of Dennis Schulz as chief executive. The main factors hurting its outcome for the full-year are losses on customer contracts, legacy commitments for earlier product generations causing on-site support costs, warranty provisions, and inventory write-downs originating from iterations of product designs during manufacturing. ITM Power outlined a 12-month priorities plan, which will be presented in full on January 31, which aims to make ITM Power a "more focused" company. It covers three main areas: its core product portfolio, plans for future testing and automation and its approach to capital allocation and costs.

----------

NewMed Energy said it continues to promote its proposed merger with Capricorn Energy on the existing terms, saying this is the most compelling option for all stakeholders. However, NewMed also says it continues to consider alternative strategic options to the merger with Capricorn, which is facing pushback on the deal from shareholder Palliser Capital Master Fund.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.